Unraveling the Mysteries of Lipoprotein(a): Insights on Aspirin Use, Heart Attack Risks, and Diet
Nov 14, 2023
auto_awesome
Dr. Kahn discusses the risks of aspirin use for high Lp(a) levels and the heightened risk post-heart attack. He also talks about heart stents, urinary albumin, and the Portfolio Diet. Chapters cover alternative treatments for stents, Lp(a) and aspirin therapy, and a cautionary tale on chelation therapy.
Daily aspirin may not be beneficial for individuals with inherited high Lp(a) levels.
Monitoring microalbumin-creatinine ratio is crucial for assessing heart disease risk in type 2 diabetes patients.
Deep dives
Overuse of Coronary Stents
A report highlighted by a business site revealed that one in five coronary stents implanted by cardiologists are unnecessary, leading to wasted $800 million annually. The analysis identified high rates of overuse at various hospitals, such as Northwest Texas Hospital with a shockingly high 52% overuse rate.
Microalbumin-Creatinine Ratio and Coronary Calcification
Research presented at the American Society of Nephrology showed that individuals with diabetes type 2 and elevated protein in their urine, known as microalbumin-creatinine ratio (MACR), exhibited higher levels of coronary calcification. This study emphasizes the importance of monitoring MACR levels in diabetes management to assess heart disease risk.
Portfolio Diet and Cardiovascular Health
The Portfolio Diet, endorsed by experts like Dr. David Jenkins, emphasizes incorporating foods rich in soluble fiber, soy protein, nuts, and plant sterols to reduce LDL cholesterol levels. Recent studies involving over 200,000 participants demonstrated that adhering to the Portfolio Diet significantly lowered the risk of cardiovascular events like heart attacks and strokes by approximately 15% over 30 years.
Many patients seek out the Kahn Center (kahnlongevitycenter.com) for consultation regarding elevated levels of Lipoprotein(a) cholesterol, also known as Lp(a). In this week's episode, Dr. Kahn discusses a new research paper, along with two others, addressing the question of whether daily aspirin is a wise choice for those who have inherited high Lp(a) levels. He also presents another recent study about the heightened risk of Lp(a) in certain patients post-heart attack.